![Pharmaceutical Patent Two-Step: The Adverse Advent of Amarin v. Hikma Type Litigation* - NYU Journal of Intellectual Property & Entertainment Law Pharmaceutical Patent Two-Step: The Adverse Advent of Amarin v. Hikma Type Litigation* - NYU Journal of Intellectual Property & Entertainment Law](https://jipel.law.nyu.edu/wp-content/uploads/2023/01/Tu_Table1.png)
Pharmaceutical Patent Two-Step: The Adverse Advent of Amarin v. Hikma Type Litigation* - NYU Journal of Intellectual Property & Entertainment Law
GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., C.A. No. 14-878-LPS-CJB (D. Del. July 20, 2016) | PDF | Generic Drug | Heart Failure
ANDA 75-298 March 23, 2001 TEVA Pharmaceuticals USA Attention: Philip Erickson 1090 Horsham Road PO BOX 1090 North Wales, PA 19
Pharma Dynamics (Pty) Ltd v Bayer Pharma AG (formerly Bayer Schering Pharma AG) and another [2014] 4 All SA 302 (SCA)
Patent Docs: Teva Pharmaceuticals Int'l GmbH v. Eli Lilly & Co., Eli Lilly & Co. v. Teva Pharmaceuticals Int'l GmbH, and Teva Pharmaceuticals Int'l GmbH v. Eli Lilly & Co. (Fed. Cir.
![More And More Are “Summarily Ghosted”: Integrilin® Is Now (June 2, 2015) Off-Patent — In The US | New Merck, Reviewed More And More Are “Summarily Ghosted”: Integrilin® Is Now (June 2, 2015) Off-Patent — In The US | New Merck, Reviewed](https://anewmerckreviewed.files.wordpress.com/2015/06/6f91e-mrk-sgp-eptif-pat-2015.png)